User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 4 results.
    • Journal article
    Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin Lymphoma and in Hodgkin Lymphoma survivors.
    Vachon, Hugo Mierzynska, Justyna Taye, Mekdes Pe, Madeline Coens, Corneel Martinelli, Francesca Fortpied, Catherine Flechtner, Henning-Hans Maraldo, Maja Vestmoe Hutchings, Martin Meijnders, Paul Aleman, Berthe Lugtenburg, Pieternella Spina, Michele André, Marc[UCL] Hertzberg, Mark Briones, Javier Bottomley, Andrew EORTC Quality of Life Group, Lymphoma Group (2021) European journal of haematology — Vol. 106, no. 5, p. 697-707 (2021)
    • Journal article
    Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study.
    Maggen, Charlotte Dierickx, Daan Lugtenburg, Pieternella Laenen, Annouschka Cardonick, Elyce Smakov, Roman Bellido, Mar Cabrera-Garcia, Alvaro Mhallem Gziri, Mina[UCL] Halaska, Michael J Ottevanger, Petronella B Van Calsteren, Kristel O'Laughlin, Andie Polushkina, Evgeniya Van Dam, Laura Avivi, Irit Vandenberghe, Peter Woei-A-Jin, F J Sherida H Amant, Frédéric International Network on Cancer, Infertility and Pregnancy (2019) The Lancet. Haematology — Vol. 6, no.11, p. e551-e561 (2019)
    • Journal article
    R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial.
    Chamuleau, Martine E D Stenner, Frank Chitu, Dana A Novak, Urban Minnema, Monique C Geerts, Paul Stevens, Wendy B C Zenz, Thorsten van Imhoff, Gustaaf W Wu, Ka Lung Demandt, Astrid M P Kersten, Marie Jose Terpstra, Wim E Tick, Lidwine W Deeren, Dries Van Den Neste, Eric[UCL] Gregor, Michael Veelken, Hendrik Böhmer, Lara H Caspar, Clemens B Mutsaers, Pim Refos, Jeannine M Sewsaran, Robby Fu, Liping Seefat, Rianne L Uyl-de Groot, Carin A Dirnhofer, Stefan Van Den Brand, Michiel de Jong, Daphne Nijland, Marcel Lugtenburg, Pieternella (2023) The Lancet. Haematology — Vol. 10, no.12, p. e966-e975 (2023)
    • Journal article
    Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial.
    Fornecker, Luc-Matthieu Lazarovici, Julien Aurer, Igor Casasnovas, René-Olivier Gac, Anne-Claire Bonnet, Christophe Bouabdallah, Krimo Feugier, Pierre Specht, Lena Molina, Lysiane Touati, Mohamed Borel, Cécile Stamatoullas, Aspasia Nicolas-Virelizier, Emmanuelle Pascal, Laurent Lugtenburg, Pieternella Di Renzo, Nicola Vander Borght, Thierry[UCL] Traverse-Glehen, Alexandra Dartigues, Peggy Hutchings, Martin Versari, Annibale Meignan, Michel Federico, Massimo André, Marc[UCL] LYSA-FIL-EORTC Intergroup (2023) Journal of clinical oncology — Vol. 41, no. 2, p. 327-335 (2023)